Mary Kay Lobo

Last updated
Mary Kay Lobo
Born1975 (age 4849)
Alma mater University of California, Los Angeles
Scientific career
Institutions University of Maryland School of Medicine
Thesis Genetic analyses of striatal projection neuron subtypes in the direct and indirect pathways  (2007)

Mary Kay Lobo (born 1975) is an American psychiatric neuroscientist who is a Professor of Neurobiology at the University of Maryland School of Medicine. Her research considers the molecular mechanisms that underpin drug addiction and depression. She was named a finalist in the 2011 Blavatnik Awards for Young Scientists.

Contents

Early life and education

Lobo was born and raised in Los Angeles. She studied biology and anthropology at the University of California, Los Angeles. She stayed in California for her doctoral research, where she completed genetic analysis of neuron subtypes. To achieve this, she had to develop a novel methodology for isolating the main striatal projection neuron subtypes (medium spiny neurons). These two neuron play opposite but complementary roles in neural circuitry. [1] She worked in the laboratory of X. William Yang in the David Geffen School of Medicine at UCLA. Lobo was a postdoctoral researcher at the University of Texas Southwestern Medical Center where she worked in the laboratory of Eric J. Nestler.[ citation needed ]

Research and career

In 2011 Lobo was appointed to the faculty at the University of Maryland School of Medicine. [2] She has continued to make use of genetic analysis to understand how neuronal circuits are involved with drug addiction and depression. [1] In such scenarios, the circuits become dysfunctional, influencing downstream brain region. [1] By combining genetic analysis with optogenetic, Lobo has identified divergent roles in nucleus accumbens projection neurons in the brain's reward centre. [1] She showed that the molecular regulator of mitochondrial fission is amplified in the brain reward regions of individuals dependent on cocaine, and that blocking this fission process can reduce cocaine-seeking behaviour. [2]

Lobo investigated effective medications and molecular targets for major depressive disorders. [3] To achieve this, she uses mouse models of depression. She showed that chronic stress decreases the number of dendrites and size of nerve cells in mice, which limits the number of connections with nearby nerve cells. [3] [4] She proposed that the small transforming protein RhoA, which is involved the maintenance of dendrite shape and size, and its molecular target rho-associated protein kinase (ROCK), offer hope for the restoration of brain function in people with major depressive disorders. [3] The use of RhoA inhibitors can result in antidepressant like responses to stress. [3]

Academic service

Lobo was made associate editor of The Journal of Neuroscience in 2014. [5] She serves on the editorial board of ACS Chemical Neuroscience and Biological Psychiatry . [6] [7]

Awards and honors

Selected publications

Related Research Articles

<span class="mw-page-title-main">Dendritic spine</span> Small protrusion on a dendrite that receives input from a single axon

A dendritic spine is a small membranous protrusion from a neuron's dendrite that typically receives input from a single axon at the synapse. Dendritic spines serve as a storage site for synaptic strength and help transmit electrical signals to the neuron's cell body. Most spines have a bulbous head, and a thin neck that connects the head of the spine to the shaft of the dendrite. The dendrites of a single neuron can contain hundreds to thousands of spines. In addition to spines providing an anatomical substrate for memory storage and synaptic transmission, they may also serve to increase the number of possible contacts between neurons. It has also been suggested that changes in the activity of neurons have a positive effect on spine morphology.

<span class="mw-page-title-main">Nucleus accumbens</span> Region of the basal forebrain

The nucleus accumbens is a region in the basal forebrain rostral to the preoptic area of the hypothalamus. The nucleus accumbens and the olfactory tubercle collectively form the ventral striatum. The ventral striatum and dorsal striatum collectively form the striatum, which is the main component of the basal ganglia. The dopaminergic neurons of the mesolimbic pathway project onto the GABAergic medium spiny neurons of the nucleus accumbens and olfactory tubercle. Each cerebral hemisphere has its own nucleus accumbens, which can be divided into two structures: the nucleus accumbens core and the nucleus accumbens shell. These substructures have different morphology and functions.

<span class="mw-page-title-main">Nigrostriatal pathway</span> Bilateral pathway in the brain

The nigrostriatal pathway is a bilateral dopaminergic pathway in the brain that connects the substantia nigra pars compacta (SNc) in the midbrain with the dorsal striatum in the forebrain. It is one of the four major dopamine pathways in the brain, and is critical in the production of movement as part of a system called the basal ganglia motor loop. Dopaminergic neurons of this pathway release dopamine from axon terminals that synapse onto GABAergic medium spiny neurons (MSNs), also known as spiny projection neurons (SPNs), located in the striatum.

<span class="mw-page-title-main">Habenula</span> Small bilateral neuronal structure in the brain of vertebrates

The habenula is a small bilateral neuronal structure in the brain of vertebrates, that has also been called a microstructure since it is no bigger than a pea. The naming as little rein describes its elongated shape in the epithalamus, where it borders the third ventricle, and lies in front of the pineal gland.

<span class="mw-page-title-main">Kalirin</span> Protein-coding gene in the species Homo sapiens

Kalirin, also known as Huntingtin-associated protein-interacting protein (HAPIP), protein duo (DUO), or serine/threonine-protein kinase with Dbl- and pleckstrin homology domain, is a protein that in humans is encoded by the KALRN gene. Kalirin was first identified in 1997 as a protein interacting with huntingtin-associated protein 1. Is also known to play an important role in nerve growth and axonal development.

Rachel Wilson is an American professor of neurobiology at Harvard Medical School and is a Howard Hughes Medical Institute Investigator. Wilson's work integrates electrophysiology, neuropharmacology, molecular genetics, functional anatomy, and behavior to explore how neural circuits are organized to react and sense a complex environment.

<span class="mw-page-title-main">Eric J. Nestler</span> Neuroscientist of addiction and depression

Eric J. Nestler is the Nash Family Professor of Neuroscience, Director of the Friedman Brain Institute, and Dean for Academic Affairs at the Icahn School of Medicine at Mount Sinai and Chief Scientific Officer of the Mount Sinai Health System. His research is focused on a molecular approach to drug addiction and depression.

<span class="mw-page-title-main">Karl Deisseroth</span> American optogeneticist (born 1971)

Karl Alexander Deisseroth is an American scientist. He is the D.H. Chen Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University.

Addiction is a state characterized by compulsive engagement in rewarding stimuli, despite adverse consequences. The process of developing an addiction occurs through instrumental learning, which is otherwise known as operant conditioning.

<span class="mw-page-title-main">Yasmin Hurd</span> American neuroscientist

Yasmin Hurd is the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute at Mount Sinai. Hurd holds appointments as faculty of Neuroscience, Psychiatry, Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City and is globally recognized for her translational research on the underlying neurobiology of substance use disorders and comorbid psychiatric disorders. Hurd's research on the transgenerational effects of early cannabis exposure on the developing brain and behavior and on the therapeutic properties of cannabidiol has garnered substantial media attention. In 2017, Dr. Hurd was elected to the National Academy of Medicine and, in 2022, Dr. Hurd was elected to the National Academy of Sciences (NAS).

<span class="mw-page-title-main">Kay Tye</span> American neuroscientist (born c. 1981)

Kay M. Tye is an American neuroscientist and professor and Wylie Vale Chair in the Salk Institute for Biological Sciences. Her research has focused on using optogenetics to identify connections in the brain that are involved in innate emotion, motivation and social behaviors.

Christian Lüscher is a Swiss neurobiologist and full professor at the Department of Basic Neurosciences of the University of Geneva. He is also an attending in neurology at the Geneva University Hospital. Lüscher is known for his contributions in the field addiction, particularly for establishing links of causality between the drug-evoked synaptic plasticity and adaptive behavior in mice.

<span class="mw-page-title-main">Viviana Gradinaru</span> American neuroscientist and biomedical engineer

Viviana Grădinaru is a Romanian-American neuroscientist who is a Professor of Neuroscience and Biological Engineering at the California Institute of Technology. She develops neurotechnologies including optogenetics CLARITY tissue clearing, and gene delivery vectors. She has been awarded the Presidential Early Career Award for Scientists and Engineers and the National Institutes of Health Director's Pioneer Award. In 2019 she was a finalist for the Blavatnik Awards for Young Scientists. In 2020 she was awarded a Vilcek Prize for Creative Promise in Biomedical Science by the Vilcek Foundation.

<span class="mw-page-title-main">Meaghan Creed</span> Canadian Neuroscientist

Meaghan Creed is a Canadian neuroscientist and associate professor of anesthesiology at Washington University in St. Louis. Creed has conducted research on understanding and optimizing deep brain stimulation in the basal ganglia for the treatment of neurological and psychiatric disorders. Her work has been recognized at the national and international level by Pfizer, the American Association for the Advancement of Science (AAAS), the Whitehall Foundation, Brain and Behavior Research Foundation and the Rita Allen Foundation.

Camilla Bellone is an Italian neuroscientist and assistant professor in the Department of Basic Neuroscience at the University of Geneva, in Switzerland. Bellone's laboratory explores the molecular mechanisms and neural circuits underlying social behavior and probes how defects at the molecular and circuit level give rise to psychiatric disease states such as Autism Spectrum Disorders. 

Ilana B. Witten is an American neuroscientist and professor of psychology and neuroscience at Princeton University. Witten studies the mesolimbic pathway, with a focus on the striatal neural circuit mechanisms driving reward learning and decision making.

<span class="mw-page-title-main">Asya Rolls</span> Israeli psychoneuroimmunologist

Asya Rolls is an Israeli psychoneuroimmunologist and International Howard Hughes Medical Institute Investigator and a Professor at the Immunology and Center of Neuroscience at Technion within the Israel Institute of Technology. Rolls leads a lab that explores how the nervous system affects immune responses and thus physical health. Her recent work has highlighted how the brain's reward system is implicated in the placebo response and how brain-immune interactions can be harnessed to find and destroy tumors.

Lauren Orefice is an American neuroscientist and assistant professor in the Department of Molecular Biology at Massachusetts General Hospital and in the Department of Genetics at Harvard Medical School. Orefice has made innovative discoveries about the role of peripheral nerves and sensory hypersensitivity in the development of Autism-like behaviors. Her research now focuses on exploring the basic biology of somatosensory neural circuits for both touch and gastrointestinal function in order to shed light on how peripheral sensation impacts brain development and susceptibility to diseases like Autism Spectrum Disorders.

Michelle Gray is an American neuroscientist and assistant professor of neurology and neurobiology at the University of Alabama Birmingham. Gray is a researcher in the study of the biological basis of Huntington's disease (HD). In her postdoctoral work, she developed a transgenic mouse line, BACHD, that is now used worldwide in the study of HD. Gray's research now focuses on the role of glial cells in HD. In 2020 Gray was named one of the 100 Inspiring Black Scientists in America by Cell Press. She is also a member of the Hereditary Disease Foundation’s scientific board.

<span class="mw-page-title-main">Casper Hoogenraad</span> Dutch biologist

Casper Hoogenraad is a Dutch Cell Biologist who specializes in molecular neuroscience. The focus of his research is the basic molecular and cellular mechanisms that regulate the development and function of the brain. As of January 2020, he serves as Vice President of Neuroscience at Genentech Research and Early Development.

References

  1. 1 2 3 4 5 6 "Mary Kay Lobo | Blavatnik Awards for Young Scientists". blavatnikawards.org. Retrieved 2021-01-09.
  2. 1 2 "#IAmNYAS: Mary Kay Lobo, PhD". New York Academy of Sciences . 2018-04-26.
  3. 1 2 3 4 "Developing Better Treatments for Depression: Dr. Mary Kay Lobo". One Mind. 2018-04-23. Retrieved 2021-01-09.
  4. "Specific Gene Could Play Key Role in Depression". Psychiatry & Behavioral Health Learning Network. Retrieved 2021-01-09.
  5. "Editorial Board | Journal of Neuroscience". www.jneurosci.org. Retrieved 2021-01-09.
  6. Biological Psychiatry Editorial Board.
  7. "Editorial Board". pubs.acs.org. Retrieved 2021-01-09.
  8. "One Mind - IMHRO: Opening up discussions on brain health". Research Features. 2016-10-31. Retrieved 2021-01-09.
  9. "NIMH » Two NIMH Grantees Receive Prestigious Presidential Award". www.nimh.nih.gov. Retrieved 2021-01-09.